Search
Search Results
##search.searchResults.foundPlural##
-
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4625PDF: 1504HTML: 2224Untitled: 187Untitled: 202Untitled: 209Untitled: 191Untitled: 187 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4175PDF: 1330HTML: 2022 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1011PDF: 524HTML: 1670Figures: 140Fifures Sanz: 154tables Sanz: 162Untitled: 152 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
1933PDF: 604HTML: 234 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2295PDF: 1345HTML: 1959 -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2197PDF: 908HTML: 11096 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2721PDF: 889HTML: 7293 -
-
CANDIDEMIA IN PATIENTS WITH ACUTE LEUKEMIA: ANALYSIS OF SEVEN YEARS’ EXPERIENCE AT A SINGLE CENTER IN CHINA Candidemia in acute Leukemia
1620PDF: 901HTML: 208 -
FUNGAL INFECTIONS OF THE EAR IN IMMUNOCOMPROMISED HOST: A REVIEW
3415PDF: 1311HTML: 3671Letter to Editor: 164 -
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
1852PDF: 1050HTML: 1884Lung computed tomography CT scan image: 182 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
692PDF: 828Suppl. Files: 105HTML: 61 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1669PDF: 1038HTML: 223 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2691PDF: 882HTML: 339Preferred Reviewers: 185 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3190PDF: 1304HTML: 2602 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
1891PDF: 782HTML: 2187Table 1: 155Table 2: 170Table 3: 166Table 4: 171Table 5: 167Tble 6: 161Cover Letter: 182Greene Tab.7: 168 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1679PDF: 637HTML: 309 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1307PDF: 683Suppl. Files: 294Html: 117 -
INVASIVE FUNGAL INFECTION IN CHILDREN WITH ACUTE LEUKEMIA AND SEVERE APLASTIC ANEMIA IFI in Children with Acute Leukemia and SAA
2519PDF: 719HTML: 192 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1655PDF: 593HTML: 1497Figure 1: MRI demonstrating Aspergillus synovitis: 165Figure 2:MRI demonstrating Aspergillus synovitis: 161 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3528PDF: 1243HTML: 694Figure 2: 414Figure 1: 3084 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4681PDF: 1701HTML: 2685Untitled: 188 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1631PDF: 775HTML: 921cover letter: 245 -
WHAT ARE FUNGAL INFECTIONS?
3992PDF: 2290HTML: 27528de Pauw: 205 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1768PDF: 873HTML: 930Referring article: 713 -
EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome
627PDF: 343HTML: 67 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1334PDF: 704HTML: 189 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
894PDF: 481HTML: 167 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3611PDF: 1198HTML: 3860Untitled: 181Untitled: 240







